| |
| |
|
| Insider
Information: |
Hearne Michael S |
| Relationship: |
Chief Financial Officer |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
2,620 |
|
|
Indirect Shares
|
12,767,435 |
|
|
| Direct
Value |
$7,465,690 |
|
|
|
Indirect Value
|
$36,380,806,033 |
|
|
| Total
Shares |
12,770,055 |
|
|
| Total
Value |
$36,388,271,723 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
20
|
3
|
|
Stock
price went up :
|
10
|
0
|
| Stock
price went down : |
10
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-3.0
|
| Percentage
Gain/Loss : |
 -17.1%
|
-97.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Odonate Therapeutics Inc |
ODT |
Chief Financial Officer |
2021-03-15 |
2,620 |
2021-11-19 |
12,767,435 |
Premium* |
|
|
La Jolla Pharmaceutical Co |
LJPC |
Chief Financial Officer |
2022-08-22 |
0 |
2022-08-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
• – – |
2021-11-17 |
4 |
S |
$1.99 |
$2,948,748 |
I/I |
(1,287,577) |
14,226,989 |
0 |
% |
|
| ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
• – – |
2021-11-18 |
4 |
S |
$1.88 |
$2,081,879 |
I/I |
(1,094,265) |
13,132,724 |
0 |
% |
|
| ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
• – – |
2021-11-19 |
4 |
S |
$1.92 |
$699,930 |
I/I |
(365,289) |
12,767,435 |
0 |
% |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2022-08-22 |
4 |
D |
$6.23 |
$63,459 |
D/D |
(10,186) |
0 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
• – – |
2022-08-22 |
4 |
D |
$6.23 |
$59,857,429 |
I/I |
(9,607,934) |
0 |
0 |
- |
|
| ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
• – – |
2018-12-06 |
4 |
B |
$14.62 |
$153,573 |
I/I |
10,500 |
12,752,838 |
1.99 |
- |
|
| ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
• – – |
2018-12-07 |
4 |
B |
$14.98 |
$142,291 |
I/I |
9,500 |
12,762,338 |
1.99 |
- |
|
| ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
• – – |
2018-12-11 |
4 |
B |
$15.25 |
$83,128 |
I/I |
5,450 |
12,767,788 |
1.99 |
- |
|
| ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
• – – |
2018-12-12 |
4 |
B |
$15.65 |
$228,946 |
I/I |
14,550 |
12,782,338 |
1.99 |
- |
|
| ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
• – – |
2018-12-14 |
4 |
B |
$15.08 |
$150,838 |
I/I |
10,000 |
12,792,338 |
1.99 |
- |
|
| ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
• – – |
2018-12-17 |
4 |
B |
$14.51 |
$268,612 |
I/I |
18,296 |
12,810,634 |
1.99 |
- |
|
| ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
• – – |
2018-12-18 |
4 |
B |
$14.13 |
$167,189 |
I/I |
11,704 |
12,822,338 |
1.99 |
- |
|
| ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
• – – |
2018-12-20 |
4 |
B |
$13.17 |
$131,742 |
I/I |
10,000 |
12,832,338 |
1.99 |
- |
|
| ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
• – – |
2018-12-21 |
4 |
B |
$12.27 |
$255,828 |
I/I |
20,000 |
12,852,338 |
1.99 |
- |
|
| ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
• – – |
2018-12-26 |
4 |
B |
$12.09 |
$368,287 |
I/I |
30,000 |
12,882,338 |
1.99 |
- |
|
| ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
• – – |
2018-12-27 |
4 |
B |
$12.03 |
$120,315 |
I/I |
10,000 |
12,892,338 |
1.99 |
- |
|
| ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
• – – |
2018-12-28 |
4 |
B |
$12.04 |
$253,863 |
I/I |
20,000 |
12,912,338 |
1.99 |
- |
|
| ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
• – – |
2018-12-31 |
4 |
B |
$13.42 |
$460,929 |
I/I |
33,700 |
12,946,038 |
1.99 |
- |
|
| ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
• – – |
2019-03-07 |
4 |
B |
$16.56 |
$681,733 |
I/I |
40,000 |
12,986,038 |
1.99 |
- |
|
| ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
• – – |
2019-03-08 |
4 |
B |
$18.10 |
$1,874,583 |
I/I |
100,000 |
13,086,038 |
1.99 |
- |
|
| ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
• – – |
2019-06-03 |
4 |
B |
$22.16 |
$343,904 |
I/I |
15,286 |
13,101,324 |
1.99 |
- |
|
| ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
• – – |
2019-06-04 |
4 |
B |
$24.92 |
$970,772 |
I/I |
38,950 |
13,140,274 |
1.99 |
- |
|
| ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
• – – |
2019-06-05 |
4 |
B |
$25.14 |
$1,020,541 |
I/I |
39,456 |
13,179,730 |
1.99 |
- |
|
| ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
• – – |
2019-06-06 |
4 |
B |
$27.56 |
$1,561,237 |
I/I |
56,308 |
13,236,038 |
1.99 |
- |
|
| ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
• – – |
2019-06-07 |
4 |
B |
$26.31 |
$526,220 |
I/I |
20,000 |
13,256,038 |
1.99 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
